AtriCure, Inc.
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Inclusion Criteria: 1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices. 2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements Exclusion Criteria: 1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS. 2. Subject with exclusion criteria required by FDA or local governance
Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.